AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
| 0.5801 BATS BZX Real-Time Price As of 3:16pm ET |  +0.0024 / +0.42%Today’s Change | 0.55 Today|||52-Week Range 4.86 | -74.33% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 19.3M | 17.4M | 8.0M | 2.2M | |
| Cost of Goods Sold | 778.0K | 10.3M | 8.9M | 3.4M | ||
| Depreciation And Amortization | 2.0M | 2.1M | 1.7M | 575.0K | ||
| Operating Expenses | Gross Income | 16.5M | 5.0M | -2.7M | -1.8M | |
| General Expenses | 35.7M | 37.0M | 36.0M | 33.9M | ||
| Research And Development | 22.5M | 21.4M | 19.4M | 13.1M | ||
| Total Operating Expenses | 38.5M | 49.3M | 46.7M | 37.9M | ||
| Non-Operating Expenses | Operating Income | -19.2M | -32.0M | -38.7M | -35.7M | |
| Extraordinary Credit | 2.1M | 600.0K | 95.0K | 86.0K | ||
| Extraordinary Charge | -756.0K | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 5.4M | 12.2M | 14.0M | 12.6M | ||
| Other Expenses | -380.0K | 318.0K | 415.0K | 1.1M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -23.6M | -43.2M | -52.2M | -47.1M | |
| Income Taxes | -760.0K | -34.0K | -701.0K | -2.0K | ||
| Net Income | -24.4M | -43.2M | -51.5M | -47.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 44.3M | 45.3M | 46.9M | 58.4M | |
| Shares To Calculate EPS Diluted | 44.5M | 45.3M | 46.9M | 58.4M | ||
| Earnings Per Share | EPS | -$0.60 | -$0.95 | -$1.10 | -$0.81 | |
| EPS Diluted | -$0.60 | -$0.95 | -$1.10 | -$0.81 | ||
